Cargando…

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging

BACKGROUND: Neuropathological studies, based on small samples, suggest that symptoms of Parkinson's disease (PD) emerge when dopamine/nigrostriatal loss is around 50–80%. Functional neuroimaging can be applied in larger numbers during life, which allows analysis of the extent of dopamine loss m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heng, Nicholas, Malek, Naveed, Lawton, Michael A., Nodehi, Anahita, Pitz, Vanessa, Grosset, Katherine A., Ben‐Shlomo, Yoav, Grosset, Donald G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105104/ https://www.ncbi.nlm.nih.gov/pubmed/37070042 http://dx.doi.org/10.1002/mdc3.13687

Ejemplares similares

Comparison between four published definitions of hyposmia in Parkinson's disease
por: Kanavou, Sofia, et al.
Publicado: (2021)

Commentary: “Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis”
por: Lawton, Michael, et al.
Publicado: (2023)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
por: Malek, Naveed, et al.
Publicado: (2017)

Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter
por: Condon, Mark D., et al.
Publicado: (2019)

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
por: Vriend, Chris, et al.
Publicado: (2020)

Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
por: Passamonti, Luca, et al.
Publicado: (2013)

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
por: Malek, Naveed, et al.
Publicado: (2016)

Investigational agents in the treatment of Parkinson’s disease: focus on safinamide
por: Malek, Naveed M, et al.
Publicado: (2012)

Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
por: Voon, Valerie, et al.
Publicado: (2014)

Variation in Recent Onset Parkinson’s Disease: Implications for Prodromal Detection
por: Swallow, Diane M.A., et al.
Publicado: (2016)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Tracking Parkinson’s: Study Design and Baseline Patient Data
por: Malek, Naveed, et al.
Publicado: (2015)

Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedonia
por: Costello, Harry, et al.
Publicado: (2023)

Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial
por: Grosset, Katherine A, et al.
Publicado: (2007)

Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies
por: van Deursen, Dagmar N., et al.
Publicado: (2020)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
por: Lawton, Michael, et al.
Publicado: (2016)

Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

Associations of striatal dopamine transporter binding with motor and non‐motor symptoms in early Parkinson's disease
por: Yang, Zhengjie, et al.
Publicado: (2023)

Reduced Striatal Dopamine Transporters in People with Internet Addiction Disorder
por: Hou, Haifeng, et al.
Publicado: (2012)

Changes in striatal dopamine transporters in bipolar disorder and valproate treatment
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2021)

Akinetic Crisis in Parkinson's Disease Is Associated with a Severe Loss of Striatal Dopamine Transporter Function: A Report of Two Cases
por: Kaasinen, Valtteri, et al.
Publicado: (2014)

Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
por: Miville-Godbout, Edith, et al.
Publicado: (2016)

Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson’s Disease
por: Lee, Jae Jung, et al.
Publicado: (2015)

Altered functional connectivity associated with striatal dopamine depletion in Parkinson’s disease
por: Shima, Atsushi, et al.
Publicado: (2023)

Dopamine regulation of striatal inhibitory transmission and plasticity: dopamine, low or high?
por: Hernández-Echeagaray, Elizabeth
Publicado: (2016)

Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease
por: Auger, Stephen D., et al.
Publicado: (2020)

Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol
por: Threlfell, Sarah, et al.
Publicado: (2021)

Local control of striatal dopamine release
por: Cachope, Roger, et al.
Publicado: (2014)

Abnormal Striatal Dopamine Transmission in Schizophrenia
por: Brunelin, Jerome, et al.
Publicado: (2013)

Striatal Dopamine Signals and Reward Learning
por: Bech, Pol, et al.
Publicado: (2023)

Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects
por: Pak, Kyoungjune, et al.
Publicado: (2017)

Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response
por: de Souza Silva, Maria A., et al.
Publicado: (2016)

Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controls
por: Wang, Chao, et al.
Publicado: (2023)

Ventral Striatal Dopamine Synthesis Capacity Predicts Financial Extravagance in Parkinson’s Disease
por: Lawrence, Andrew D., et al.
Publicado: (2013)

Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease
por: Chung, Su Jin, et al.
Publicado: (2016)

Reduced striatal dopamine release during motor skill acquisition in Parkinson’s disease
por: Kawashima, Shoji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f90g3b5ps785uo9b0gatn4s926